全腺治疗（根治性前列腺切除和放射治疗）一直是局部前列腺癌的传统治疗，但与观察性等待或主动监测相比，随机对照试验并未显示出生存益处。全腺治疗也与显著的长期后遗症有关，包括尿失禁、勃起功能障碍、辐射性膀胱炎和直肠炎。
适应症：Prostate Cancer
入组条件
纳入标准
- Patients who have undergone focal therapies for prostate cancer at the Department of Surgery, Queen Mary Hospital
- Includes but not limited to: cryotherapy, high-intensity focused ultrasound (HIFU), focal laser therapy (FLA), and irreversible electroporation (IRE)
- Willing and able to provide written informed consent
排除标准
- Patients who are incapable to provide written informed consent.
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。